BioType

BioType

Dresden, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

BioType is a commercial-stage, private German diagnostics company specializing in molecular precision diagnostics for hemato-oncology and clinical research. Its business is built on a proprietary multi-biomarker testing platform (MODAPLEX) and a portfolio of CE-marked IVD kits for Acute Myeloid Leukemia (AML) profiling and chimerism monitoring post-transplant. The company is actively expanding its commercial reach through new distribution partnerships across Europe and is engaged in the local Saxony life sciences ecosystem, indicating a focus on growth and collaboration.

OncologyHemato-Oncology

Technology Platform

Proprietary MODAPLEX Platform: a benchtop system for integrated, comprehensive multi-biomarker testing in a single workflow. Supports multiplexed molecular analysis for clinical diagnostics and research.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The global shift towards multiplexed, panel-based testing in precision oncology presents a significant opportunity for BioType's MODAPLEX platform.
Additionally, expanding its distribution network into new European and international markets can drive near-term revenue growth for its established diagnostic kits.

Risk Factors

BioType faces intense competition from large global diagnostics corporations and the pervasive adoption of next-generation sequencing (NGS).
Regulatory hurdles under the new EU IVD Regulation (IVDR) and dependence on reimbursement for its niche hemato-oncology tests also pose significant commercial risks.

Competitive Landscape

BioType competes in the specialized molecular diagnostics for oncology space. Key competitors include large, diversified IVD companies like Roche, Abbott, and Qiagen, which offer broad oncology panels, as well as smaller niche players and the overarching disruptive threat of comprehensive NGS-based profiling solutions from companies like Illumina and Thermo Fisher.